Febuxostat protects HAVECs from ox-LDL-induced injury and monocyte attachment.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of cardiovascular pharmacology"
DOI: 10.1097/fjc.0000000000001326
Abstract: ABSTRACT Atherosclerosis (AS) is a common cardiovascular disease with high morbidity and mortality. The pathogenesis of AS is closely related to endothelial dysfunction, which is mainly induced by oxidative stress, inflammation, and enhanced adhesion of… read more here.
Keywords: induced injury; injury monocyte; febuxostat; ldl ... See more keywords